BriaCell Share Price
NASDAQ: BCTXZ | Micro Cap | HealthcareBriaCell Stock Performance
BriaCell Share Price Today
As of 22 November 2026, BriaCell Therapeutics Corp. Warrant expiring 2030's share price is $0.11. The stock opened at $0.13, compared to its previous close of $0.11. During today's trading session, BriaCell Therapeutics Corp. Warrant expiring 2030's share price traded between $0.11 and $0.13, with an average price of $0.12. Over the past 52 weeks, the stock has recorded a high of $0.42 and a low of $0.08. In terms of performance, BriaCell Therapeutics Corp. Warrant expiring 2030's share price has risen by 20.00% over the last six months and is down 74.10% on a year-on-year basis.
BriaCell Share Price Chart
BriaCell Quarterly Profit & Loss
All figures in USD
BriaCell Annual Profit & Loss
All figures in USD
BriaCell Balance Sheet
All figures in USD Million
BriaCell Cash Flow
All figures in USD Million
About BriaCell
BriaCell Therapeutics Corp is a clinical-stage biotechnology company developing targeted immunotherapies to transform cancer care. Its Bria-IMT targeted immunotherapy is being developed in combination with the immune checkpoint inhibitor Retifanlimab in a pivotal Phase 3 study in metastatic breast cancer. The Company's operations focus on the research and development of its immunotherapy product candidates and related supporting activities.
BriaCell Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.14 | $0.11 | -61.43% |
Oct 2026 | $0.28 | $0.28 | +47.37% |
Sep 2026 | $0.19 | $0.19 | +126.19% |
Aug 2026 | $0.08 | $0.08 | -6.67% |
Jul 2026 | $0.10 | $0.09 | +12.50% |
Jun 2026 | $0.08 | $0.08 | -11.11% |
Apr 2026 | $0.15 | $0.09 | -21.05% |
Mar 2026 | $0.16 | $0.11 | -25.49% |
Feb 2026 | $0.14 | $0.15 | -10.00% |
Jan 2026 | $0.28 | $0.17 | -37.04% |
Dec 2025 | $0.42 | $0.27 | -16.41% |
Nov 2025 | $0.36 | $0.32 | -22.54% |